PT-141 10mg peptide
PT-141 10mg peptide: a research vial of PT-141, the peptide also called bremelanotide, studied in two large phase 3 trials; this research-grade vial is not the prescription medicine approved in 2019, and a 2024 review questioned those trials.
3,600,000 VND ($140 USD) for 1 vial
Stock and the total are confirmed on WhatsApp.
USD prices are the store's dollar prices; you pay the VND price.
Free tracked delivery to Hanoi in 1 to 3 days, no minimum order. Each vial comes with a bottle of bacteriostatic water and a container. Research use only: not an approved medicine, and no medical advice.
What is PT-141?
PT-141 10mg, also called bremelanotide, is a ring of seven amino acids made in the lab, whose trials measured sexual desire. Its record holds both large trials and a sharp critique of them.
United States regulators approved bremelanotide in 2019 as a prescription medicine for premenopausal women with low sexual desire. The research-grade vial sold here is a different product and has no approval for use in people.
Its nearest relative in this catalogue is MT-2. Where some compounds act on blood flow, PT-141 acts through receptors in the brain.
Its human research has travelled further than most in this catalogue, from small early studies all the way to a pair of large phase 3 trials, both in women.
What the 4 PubMed papers cited for PT-141 looked at, 2006 to 2024
In a 2006 crossover study, 18 premenopausal women with low arousal each had bremelanotide on one occasion and placebo on another, and rated their desire.
The two phase 3 trials were later pooled in a 2022 analysis covering 1,202 premenopausal women with low desire, followed for 24 weeks against placebo, with desire scores and distress as the measures. A 2019 drug profile documented the American approval that followed, for the same group of women.
A 2024 review of the phase 3 data pushed back on how those trials were scored, questioning several of the scoring tools.
The trials and the critique belong together; neither tells the whole story on its own.
Sources: J Sex Med 2006; J Womens Health (Larchmt) 2022; Drugs 2019; J Sex Res 2024.
Reading the PT-141 record
PT-141 offers a clear lesson in reading trials. The phase 3 programme was large, and it measured desire scores and distress. A later review questioned several of the scoring tools used.
Both readings rest on the same data. The difference lies in how a measured change should be judged. This page gives both, because a reader needs both to weigh the record.
The 2006 study had eighteen women before menopause with low arousal. Each had both bremelanotide and a placebo, one after the other, so every woman served as her own comparison. The two large phase 3 trials are discussed in the 2024 review cited here.
Questions about PT-141
Is PT-141 the same as bremelanotide?
Yes. Bremelanotide is the drug name of the peptide sold here as PT-141.
What did the phase 3 trials measure?
Desire scores and distress, in 1,202 premenopausal women with low desire over 24 weeks against placebo; a 2024 review questioned several of the scoring tools.
Does the 2019 approval cover this vial?
No. It covers a prescription medicine, and this research-grade vial has no approval for use in people.
PT-141 10mg prices
| Pack | Total | Each vial | Per mg |
|---|---|---|---|
| 1 vial | 3,600,000 VND ($140 USD) | 3,600,000 VND ($140 USD) | 360,000 VND ($14.00 USD) |
| Pack of 3 | 8,748,000 VND ($340.20 USD) | 2,916,000 VND ($113.40 USD) | 291,600 VND ($11.34 USD) |
| Pack of 5 | 12,960,000 VND ($504 USD) | 2,592,000 VND ($100.80 USD) | 259,200 VND ($10.08 USD) |
| Pack of 10 | 21,600,000 VND ($840 USD) | 2,160,000 VND ($84 USD) | 216,000 VND ($8.40 USD) |
Near PT-141 in the list of 42
PT-141 follows Kisspeptin-10 10mg and comes before SLU-PP-332 5mg in the list of 42. Its tanning relative, MT-2 10mg, sits a few places higher up.
- AOD-9604 10mg, 3,400,000 VND ($135 USD) a vial
- Kisspeptin-10 10mg, 2,400,000 VND ($95 USD) a vial
- SLU-PP-332 5mg, 4,700,000 VND ($185 USD) a vial
- 5-Amino-1MQ 50mg, 3,600,000 VND ($140 USD) a vial